Released April 5, 2025
In this episode, Dr. Diego Delgado discusses how to manage patients with mixed phenotype hereditary transthyretin amyloidosis.Released April 5, 2025
Dre Geneviève Matte discutera de la prise en charge des patients atteints d'amyloïdose à transthyrétine héréditaire à phénotype mixteReleased March 26, 2025
In this episode, Dr. Michael Chu discusses the management of PN associated with BV in cHL.Released March 27, 2025
Dans cette episode, Christopher Lemieux discute la PN associée au BV utilisé pour la traitement de cHL.Released December 29, 2024
In this episode, Dr. Versha Banerji and Dr. Jennifer Brown discuss highlights from ASH 2024 on the treatment of CLL.Released September 4, 2024
In this episode, Dr. Versha Banerji discusses the potential impact of non-covalent BTKis for the treatment of CLL.Released July 2, 2024
In this episode, Dr. Versha Banerji, Dr. Sarit Assouline, and Dr. Christopher Hillis discuss highlights from EHA 2024 on the treatment of CLL.Released June 18, 2024
In this episode, Dr. Stephen Opat discusses the BGB-11417-101 study looking at sonrotoclax + zanubrutinib for the treatment RR CLL.Released April 24 2024
In this episode, Dr. Barbara Melosky discusses cutting edge approaches to the treatment of Lung Cancer, including the use of artificial intelligence and novel therapeutic approaches such as cancer vaccines and new targeted therapies.Released April 18 2024
In this episode, Dr. Brezden-Masley (medical oncologist) and Dr. Streutker (pathologist) discuss the latest biomarkers that may inform treatment of upper GI cancer.Released March 25 2024
In this episode, Dr. Mark Taylor discusses the surgical implications for the treatment of cSCC.Released March 25 2024
In this episode, Dr. Evan Lipson discusses the use of immunotherapy for patients with skin cancer who have had a kidney transplant.Released December 18 2023
In this episode, Dr. Rami Kotb and Dr Donna Reece discuss results of the CMRG Isa-CYBORD trial presented at the ASH 2023.Released December 11 2023
In this episode, Dr. Jennifer Brown discusses updated results from the ALPINE trial of zanubrutinib vs ibrutinib for the treatment of CLL.Released October 26 2023
In this fifth episode, Dr. Thomas Powles, Dr. Normand Blais, Dr. Srikala Sridhar, and Dr. Bernie Eigl, discuss the impact of new data from trials on 1L LA/mUC at ESMOReleased October 12 2023
In this fourth episode taken from the UC webinar, Drs Normand Blais, Terence Friedlander, and Srikala Sridhar provide their perspective in a round table discussion.Released October 10 2023
This episode with Dr. Srikala Sridhar presents a clinical case on the treatment of la/mUC.Released October 5 2023
This episode with Dr. Normand Blais discusses the unmet treatment needs for la/mUC in the 1L setting in Canada.Released September 28 2023
This episode with Dr. Normand Blais discusses the unmet treatment needs for la/mUC in the 1L setting in Canada.Released June 19 2023
This episode with Dr. Nimira Alimohamed and Dr. Minna Woo discusses the management of hyperglycemia with the use of EV in the treatment of patients with la/mUC.Released June 19 2023
This episode with Dr. Emina Torlakovic discusses the role of external quality assurance in improving the quality of biomarker assays in oncology.Released May 2023
This podcast series hosted by NMOSD patients, Lelainia Lloyd and Debbie Leticq is an education series for NMOSD patients worldwide.Released May 15 2023
In this episode hosted by Dr Srikala Sridhar, Dr Warren Mason discusses the management of peripheral neiuropathy with EV in the treatment of patients with la/mUC.Released April 28 2023
In this episode hosted by Dr Normand Blais, Dr Joel Claveau discusses the management of skin reactions with EV in the treatment of patients with la/mUC.Released April 28 2023
In this episode, Dr Normand Blais introduces the use of EV for the treatment of patients with la/mUC in a discussion with Dr Joel Claveau.Released April 3 2023
In this episode, we talk with Dr. Laurie Sehn, Dr. Matthew Davids, and Dr. Constantine Tam live from the CCOLD meeting in Banff, AB about the treatment of CLL. Transcript available.Released March 25, 2023
In this episode, we talk with Dr. Matthew Davids live from the CCOLD meeting in Banff, AB about the treatment of CLL.Released March 13, 2023
In this episode, we talk with Dr. Jessica McAlpine (gynecological oncologist) and Dr. Mary Kinloch (pathologist) about current and future biomarkers for the treatment of endometrial cancer.Released December 19, 2022
In this episode, we talk with Dr. Laurie Sehn about the impact on Canadian practice of the results of the ALPINE trial comparing zanubrutinib to ibrutinib for the treatment of CLL.Released December 14, 2022
In this episode, we talk with Dr. Jennifer Brown about the results of the ALPINE trial comparing zanubrutinib to ibrutinib for the treatment of CLL.Released October 7, 2022
In this episode, we talk with Dr. Howard Lim about current and emerging systemic treatments for advanced, unresectable BTCs.Released September 16, 2022
In this episode, we talk with Dr. David Cescon about diagnostic, prognostic, and predictive biomarkers for the treatment of breast cancer.Released August 19, 2022
In this episode, we talk with Dr. Juthaporn Cowan about COVID-19 pre-exposure prophylaxis for immunocompromised patients.Released August 16, 2022
In this episode, we talk with Dr. Dimas Yusuf about COVID-19 pre-exposure prophylaxis for patients with cancer.Released July 12, 2022
In this episode, we talk with Dr. Laurie Sehn about COVID-19 pre-exposure prophylaxis for patients with hematological malignancies.Released July 7, 2022
In this episode, we talk with Dr. Annick Dufour about the pharmacist's perspective around COVID-19 prophylaxis for our most vulnerable populations.Released June 16, 2022
In this episode, we talk with Dr. Nimira Alimohamed about the results of the EV-301 trial presented at ASCO 2022 for the treatment of advanced urothelial carcinoma.Released May 24, 2022
In this episode we talk with Dr. James Bentley about immunotherapy and biomarker testing for metastatic cervical cancer.Released May 19, 2022
In this episode, we talk with Dr. Martin Smoragiewicz about the medical oncologist’s role in managing patients with HNSCC, and how immunotherapies fit in to their practice.Released May 2, 2022
In this episode, we talk with Dr. Anna Tinker about the development of a pan-Canadian consensus paper on the selection and use of PARP inhibitors for first-line maintenance treatment in ovarian cancer.Released April 25, 2022
In this episode, we talk with Dr. Antoine Eskander about PD-L1 testing for HNSCC from a surgical oncologist's perspective.Released April 4, 2022
In this episode, we talk with Dr. Matthew Cecchini about PD-L1 testing for HNSCC from a pathologist's perspective.Released March 21, 2022
In this episode, we talk with Dr Stephen Chia about the use of biomarkers to determine which patients with TNBC can benefit from immunotherapy.Released March 21, 2022
In this fifth episode of the series, we talk with Dr Alex Carignan about immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination. (In French)Released March 14, 2022
In this fourth episode of the series, we talk with Dr. Carolyn Owen about immunization against COVID-19 and protecting patients with hematologic malignancies who are not able to mount a sufficient antibody response to vaccination.Released March 11, 2022
In this third episode of the series, we talk with Ajit Johal about immunization against COVID-19 and the pharmacist's role in protecting our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.Released March 8, 2022
In this episode, we discuss the use of zanubrutinib for the treatment of Waldenström’s Macroglobulinemia with Dr. Constantine Tam and Dr. Carolyn Owen.
Released March 8, 2022
In this second episode of the series, we talk with Dr. Zain Chagla about protecting patients with solid organ transplantation from COVID-19.Released March 8, 2022
In this introductory episode, we talk with Dr. Brian Conway about immunization against COVID-19 and how we can protect our most vulnerable populations who are not able to mount a sufficient antibody response to vaccination.Released February 7, 2022
In this episode, we talk with Dr. Rosalyn Juergens, a medical oncologist at the Juravinski Cancer Center in Hamilton, ON, about the evolving biomarker landscape in gastrointestinal malignancies and some of the advantages and challenges of implementing and accessing biomarker testing.Released January 10, 2022
This episode features a debate between Dr. Taymaa May, Surgical Scientist at the University Health Network and Professor at the University of Toronto and Dr. James Bently, Professor and Head of the Department of Obstetrics and Gynaecology at Dalhousie University on whether first-line maintenance therapy with PARP inhibitors can be considered a curative strategy in patients with advanced, BRCA-mutated epithelial ovarian cancer.Released December 7, 2021
In this episode, we talk with Dr. Janice Kwon, Professor, Department of Obstetrics and Gynecology, University of British Columbia, BC and Dr. Alon Altman, Gynecologist Oncologist and Professor, University of Manitoba, MB about the importance of BRCA testing for advanced epithelial ovarian cancer.Released November 29, 2021
In this episode, we talk with Dr. Neil Fleshner, Professor of Surgery at the University of Toronto about the evolution and uptake of genetic testing in prostate cancer.Released November 26, 2021
In this episode, we talk with Dr. Raul Gonzalez, Professor of Pathology at Harvard Medical School about genomic testing methodology, particularly for mismatch repair deficiency, as well as potential emerging biomarkers for metastatic colorectal cancer.Released September 27, 2021
In this episode, we talk with Dr. Sharlene Gill, Professor of Medicine at the University of British Columbia about the current standards for molecular testing in metastatic colorectal cancer.Released September 2, 2021
In this episode, we talk with Dr. Stephen Lam, Professor of Medicine at the University of British Columbia, and Dr. Rakesh Patel, General Practitioner at the Silverado Medical Clinic in Calgary.Released September 2, 2021
On discute avec Dre Nicole Bouchard, Pneumologue au département de médecine de l’Université de Sherbrooke, et Dr Richard Dumouchel, Omnipraticien à la Clinique médicale du Coteau, à Saint-Jean-sur-Richelieu, Québec.Released September 2, 2021
In this episode, we talk with Dr. Donna Maziak, thoracic surgeon and surgical oncologist at the Ottawa Hospital, and Chantal Bornais, nurse navigator at the Ottawa Hospital.Released September 1, 2021
In this episode, we talk with Dr. Paul Wheatley Price, Associate Professor at the University of Ottawa and Dr. Jeffery Habert, General Practitioner in Thornhill, ON about lung cancer screening programs in Canada.Released July 13, 2021
In this episode, we talk with Dr. John Kuruvilla, Associate Professor of Medicine at the University of Toronto and Princess Margaret Hospital in Toronto about novel therapies for the treatment of Hodgkin's lymphoma.Released July 13, 2021
In this fourth episode of the series, we talk with Barry Stein, President & CEO of Colorectal Cancer Canada about genomic testing in colorectal cancer. The full CGP report can be found here: https://www.impactmedicom.com/publications/reports.Released April 21, 2021
In this third episode of the series, we talk with Dr. Brandon Sheffield, anatomical pathologist at William Osler Health System in Brampton, ON about CGP from a laboratory perspective. The full CGP report can be found here: https://www.impactmedicom.com/publications/reports.Released April 28, 2021
This series is aimed at health care professionals who are at the front lines of vaccine delivery to help address common sources of misinformation around COVID-19 vaccines. In the third episode, we talk with Dr. Raywat Deonandan, Associate Professor & Epidemiologist at the University of Ottawa.Released April 21, 2021
This series is aimed at health care professionals who are at the front lines of vaccine delivery to help address common sources of misinformation around COVID-19 vaccines. In the second episode, we talk with Dr. Lynora Saxinger, world-renowned infectious disease specialist based at the University of Alberta.Released April 14, 2021
This series is aimed at health care professionals who are at the front lines of vaccine delivery to help address common sources of misinformation around COVID-19 vaccines. In the first episode, we talk with Dr. Kelly Grindrod, Associate Professor at the University of Waterloo, about common sources of misinformation and how these can be addressed. This episode is divided into 2 parts.Released April 14, 2021
This series is aimed at health care professionals who are at the front lines of vaccine delivery to help address common sources of misinformation around COVID-19 vaccines. In the first episode, we talk with Dr. Kelly Grindrod, Associate Professor at the University of Waterloo, about common sources of misinformation and how these can be addressed. This is the second part of Episode 1.Released March 24, 2021
In this second episode of the series, we discuss the BC OncoPanel, challenges for including CGP in lab budgets, the information exchange needed between stakeholders to accelerate access, and how the CGP report can provide decision makers with a framework for implementing CGP testing. The full CGP report can be found here: https://www.impactmedicom.com/publications/reports.
Released Feb 19, 2021
In this first episode of the series, we discuss the importance of CGP as a critical tool for treating patients with advanced solid tumors. We discuss a CGP report, which was developed to aid Canadian decision makers in the prioritization of funding access to CGP testing in patients with solid tumors. The full CGP report can be found here: https://www.impactmedicom.com/publications/reports.
Released Feb 5, 2021
We discuss the use of Bruton's Tyrosine Kinase (BTK) inhibitors for the treatment of patients with chronic lymphocytic leukemia (CLL) with Dr. Carolyn Owen, hemato-oncologist at the Tom Baker Cancer Center in Calgary, Alberta. A press release on results of the ELEVATE-RR trial can be found here: https://www.cancernetwork.com/view/acalabrutinib-meets-primary-end-point-versus-ibrutinib-in-previously-treated-high-risk-cll
Released Oct 28, 2020
We discuss the management of patients with chronic lymphocytic leukemia (CLL) with Dr. Michel Pavic, who is a Medical Oncologist and Chief of the Hemato-Oncology department at the Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre Hospitalier Universitaire de Sherbrooke and an assistant professor in the Faculty of Medicine and Health Sciences at the Université de Sherbrooke. The Canadian recommendations for treating CLL during COVID-19 can be found here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7339858/pdf/conc-27-e332.pdf
Released October 23, 2020
We discuss the virtual management of patients with inflammatory arthritis with Rheumatologist, Dr. Janet Pope, who is a Professor of Medicine in the Division of Rheumatology, Epidemiology and Biostatistics at the University of Western Ontario.
Released October 22, 2020
Pharmacists, Dr. Ross Tsuyuki (professor and chair of the Department of Pharmacology in the Faculty of Medicine and Dentistry at the University of Alberta) and Mark Barnes (Owner of Respect Rx Pharmacies in Ottawa), discuss the opioid epidemic in Canada and use of naloxone to prevent death from opioid overdose. The naloxone guidelines for pharmacists can be found here: https://journals.sagepub.com/doi/pdf/10.1177/1715163520949973
Released October 14, 2020
Dr. Ray Deonandan, Canadian epidemiologist, assistant director, and associate professor at the University of Ottawa, discusses how to more safely play sports with others during the COVID-19 pandemic.
**Funding for our podcast provided by Seagen, BeiGene, AstraZeneca, Merck, Alexion